Biolinq is a cutting-edge company dedicated to revolutionizing biosensing and biowearables, particularly in the metabolic health sector. They have developed a new category of tiny, electrochemical biowearable sensors that continuously monitor analytes such as glucose just below the surface of the skin, providing unprecedented real-time health insights. Their mission is to bring biosensing and biowearables mainstream over the next decade by delivering innovative, reliable, and comfortable biowearable experiences through state-of-the-art precision manufacturing, proprietary microarray platform architecture, and advanced materials science.

The company is led by a world-class team of experts with decades of experience in biosensor technology, medical devices, and metabolic health. Rich Yang serves as CEO, bringing 25 years of expertise in glucose sensing product management and strategy. Jared Tangney, PhD, is President & CTO and co-founder with deep experience in micro-array sensor research. The team includes leaders in R&D, engineering, regulatory affairs, and corporate development, contributing to Biolinq's breakthrough innovations and scale-up manufacturing capabilities. Their work is focused on delivering a profound and novel biowearable experience that integrates advanced sensor technologies with consumer electronics and software-driven insights.